Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |